The Rise of Human Factors in Medication Safety Research.
Sutherland A;Phipps DL; (2020) Joint Commission Journal on Quality and Patient Safety. 46
I qualified as a pharmacist in 2002 and have worked entirely in hospitals since then. I specialised in paediatric clinical pharmacy early in my career and have worked as a Paediatric Critical Care pharmacist in Glasgow and Manchester. I've contributed to national improvement pathways including the implementation of safer intravenous fluids for children and young people, standardisation of infusion concentrations for children and neonates, and the study and implementation of "smart" pump technologies in complex organisations.
In 2017 I was awarded a prestigious NIHR Clinical Doctoral Research Fellowship and I recently completed by PhD under Professor Darren Ashcroft at the University of Manchester. My topic was the study of medication safety systems for hospitalised children and young people using Human Factors methodology.
My research interests are around systems approaches to medicines safety, particularly learning how complex systems function in the real world, and consequently learning from how things go right. I am interested in resilience and recovery, and the empowerment and involvement of parents and young people in medicines safety research.
Medication safety
Paediatric medicines optimisation
Human Factors and Ergonomics
Complex systems
Functional resonance analysis method applications in healthcare
Qualitative health services research
Ethnomethodology
Quality improvement methodology
Sutherland A;Phipps DL; (2020) Joint Commission Journal on Quality and Patient Safety. 46
Fairer, JM; Playfor, S; Sutherland, AB; Tume, LN (2024) Intensive and Critical Care Nursing.
Sutherland, A (2023) Journal of Patient Safety.
Jandot E;Savelli M;Pinte G;Sutherland A;Quessada T;Valla FV; (2023) Nutrition In Clinical Practice : Official Publication Of The American Society For Parenteral And Enteral Nutrition. 38
Sutherland, A (2022) Drug Safety. 45
Sutherland A;Gerrard WS;Patel A;Randall M;Weston E; (2022) Bmj Open Quality. 11
Alghamdi AA;Keers RN;Sutherland A;Hann M;Gray J;Mason G;Isaac RE;Ashcroft DM; (2022) British Journal of Clinical Pharmacology. 88
Alghamdi AA;Keers RN;Sutherland A;Carson-Stevens A;Ashcroft DM; (2021) Paediatric Drugs. 23
Sutherland A;Canobbio M;Clarke J;Randall M;Skelland T;Weston E; (2020) European Journal of Hospital Pharmacy: Science and Practice. 27
Sutherland A;Phipps DL;Tomlin S;Ashcroft DM; (2019) BMC Pediatrics. 19
Sutherland A;Ashcroft DM;Phipps DL; (2019) Archives of Disease in Childhood. 104
Alghamdi AA;Keers RN;Sutherland A;Ashcroft DM; (2019) Drug Safety. 42
Oskarsdottir T;Harris D;Sutherland A;Wignell A;Christiansen N; (2018) Journal of Pharmacy and Pharmacology. 70